- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 285/08 - 1,2,4-ThiadiazolesHydrogenated 1,2,4-thiadiazoles
Patent holdings for IPC class C07D 285/08
Total number of patents in this class: 302
10-year publication summary
|
34
|
37
|
18
|
21
|
19
|
15
|
22
|
11
|
9
|
8
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer Cropscience AG | 1847 |
11 |
| Takeda Pharmaceutical Company Limited | 2713 |
10 |
| Merck Sharp & Dohme LLC | 3734 |
10 |
| Xenon Pharmaceuticals Inc. | 196 |
8 |
| Betagenon AB | 24 |
7 |
| Remynd NV | 25 |
7 |
| Bayer AG | 3490 |
6 |
| Bristol-myers Squibb Company | 4725 |
5 |
| Aurigene Discovery Technologies Limited | 92 |
5 |
| Cedars-Sinai Medical Center | 1201 |
5 |
| Cornell University | 3421 |
5 |
| Medshine Discovery Inc. | 587 |
5 |
| Novita Pharmaceuticals, Inc. | 24 |
5 |
| ASD Therapeutics Partners LLC | 5 |
4 |
| KYORIN Pharmaceutical Co., Ltd. | 162 |
4 |
| Romark Laboratories L.C. | 44 |
4 |
| Sanford-Burnham Medical Research Institute | 125 |
4 |
| Sanford Burnham Prebys Medical Discovery Institute | 307 |
4 |
| Agc, Inc. | 5483 |
4 |
| Merck Sharp & Dohme Corp. | 2183 |
3 |
| Other owners | 186 |